Skip to main content
. 2020 Mar 13;12(3):e7260. doi: 10.7759/cureus.7260

Table 1. Antimicrobial resistant rates of Enterobacteriaceae (n = 168) collected from clinical specimens of patients at hospitals in Khartoum state, Sudan.

  Agent E. coli (n = 81) K. pneumoniae (n = 52) A. baumannii (n = 12) Proteus mirabilis (n = 10) Enterobacter cloacae (n = 8) Other Gram negative rods (n = 5) Overall resistance (n = 168)
Amikacin 3.7 (3) 9.6 (5) 66.7 (8) 30 (3) 0.0 (8) 40 (2) 12.5 (21)
Augmentin 93.8 (76) 96.6 (50) 100 (12) 100 (10) 100 (8) 100 (5) 95.8 (161)
Amoxicillin 98.8 (80) 98.1 (51) 100 (12) 100 (10) 100 (8) 100 (5) 98.8 (166)
Ceftazidime 93.8 (76) 92.3 (48) 100 (12) 90 (9) 75 (6) 80 (4) 92.3 (157)
Ceftriaxone 91.4 (74) 94.2 (49) 100 (12) 90 (9) 75 (6) 4 (80) 91.7 (154)
Cefuroxime 96.3 (78) 96.0 (50) 100 (12) 90 (9.0) 100 (8.0) 100 (5.0) 96.4 (162)
Cefotaxime 93.8 (76) 92.3 (48) 100 (12) 90 (9.0) 62.5 (5) 80 (4) 91.7 (154)
Ciprofloxacin 76.5 (62) 61.5 (32) 100 (12) 80 (8) 50 (4.0) 80 (4.0) 72.6 (122)
Ofloxacin 76.5 (62) 63.5 (33) 100 (12) 80 (8.0) 50 (4.0) 80 (4.0) 73.2 (123)
Nitrofurantoin 22.2 (18) 57.7 (30) 91.7 (11) 80 (8.0) 50 (4.0) 100 (5.0) 45.2 (76)
Cefoxitin 38.3 (31) 40.4 (21) 100 (12) 100 (10) 100 (8.0) 60 (3.0) 44.6 (75)
Imipenem 7.4 (6.0) 34.6 (18) 75 (9.0) 10 (1) 37.5 (3.0) 40 (2.0) 23.2 (39)
Trimethoprim/sulfamethoxazole 75.3 (61) 75 (39) 100 (12) 90 (9.0) 50 (4.0) 100 (5.0) 77.4 (130)
Gentamicin 34.6 (28) 46.2 (24) 83.3 (10) 70 (7.0) 62.5 (5.0) 60 (3.0) 45.8 (77)